Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Utilization of serologic assays to support efficacy of vaccines in nonclinical and clinical trials: meeting at the crossroads.

Madore DV, Meade BD, Rubin F, Deal C, Lynn F; Meeting Contributors.

Vaccine. 2010 Jun 23;28(29):4539-47. doi: 10.1016/j.vaccine.2010.04.094. Epub 2010 May 12.

2.

Approach to validating an opsonophagocytic assay for Streptococcus pneumoniae.

Hu BT, Yu X, Jones TR, Kirch C, Harris S, Hildreth SW, Madore DV, Quataert SA.

Clin Diagn Lab Immunol. 2005 Feb;12(2):287-95.

3.
4.

Assignment of weight-based antibody units for 13 serotypes to a human antipneumococcal standard reference serum, lot 89-S(f).

Quataert SA, Rittenhouse-Olson K, Kirch CS, Hu B, Secor S, Strong N, Madore DV.

Clin Diagn Lab Immunol. 2004 Nov;11(6):1064-9.

5.

Long-term antibody levels and booster responses in South African children immunized with nonavalent pneumococcal conjugate vaccine.

Huebner RE, Mbelle N, Forrest B, Madore DV, Klugman KP.

Vaccine. 2004 Jul 29;22(21-22):2696-700.

PMID:
15246599
6.

Theoretic coverage of heptavalent pneumococcal conjugate vaccine in the prevention of community-acquired pneumonia in children in Italy.

Esposito S, Madore DV, Gironi S, Bosis S, Tosi S, Bianchi C, Cimino C, Principi N.

Vaccine. 2003 Jun 20;21(21-22):2704-7.

PMID:
12798607
7.
8.
9.

A multi-laboratory evaluation of an enzyme-linked immunoassay quantitating human antibodies to Streptococcus pneumoniae polysaccharides.

Quataert S, Martin D, Anderson P, Giebink GS, Henrichsen J, Leinonen M, Granoff DM, Russell H, Siber G, Faden H, Barnes D, Madore DV.

Immunol Invest. 2001 Aug;30(3):191-207.

PMID:
11570640
10.

Safety and immunogenicity of four doses of Neisseria meningitidis group C vaccine conjugated to CRM197 in United States infants.

Rennels MB, Edwards KM, Keyserling HL, Reisinger K, Blatter MM, Quataert SA, Madore DV, Chang I, Malinoski FJ, Hackell JG, Paradiso PR.

Pediatr Infect Dis J. 2001 Feb;20(2):153-9.

PMID:
11224833
11.
12.

An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study.

Plikaytis BD, Goldblatt D, Frasch CE, Blondeau C, Bybel MJ, Giebink GS, Jonsdottir I, Käyhty H, Konradsen HB, Madore DV, Nahm MH, Schulman CA, Holder PF, Lezhava T, Elie CM, Carlone GM.

J Clin Microbiol. 2000 Jun;38(6):2043-50.

13.

Use of animal testing for evaluating glycoconjugate vaccine immunogenicity.

Madore DV, Strong N, Eby R.

Dev Biol Stand. 1999;101:49-56.

PMID:
10566775
14.

Kinetics of antibody response to Haemophilus influenzae type b vaccines. Pennridge Pediatric Associates.

Madore DV, Johnson-Kraines CL, Rothstein EP, Smith DH.

Curr Med Res Opin. 1999;15(2):105-12.

PMID:
10494493
15.

Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers.

Shinefield HR, Black S, Ray P, Chang I, Lewis N, Fireman B, Hackell J, Paradiso PR, Siber G, Kohberger R, Madore DV, Malinowski FJ, Kimura A, Le C, Landaw I, Aguilar J, Hansen J.

Pediatr Infect Dis J. 1999 Sep;18(9):757-63.

PMID:
10493334
16.
17.
18.

Use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometric assay for assessment of the phagocytic capacity of serotype-specific antibodies.

Jansen WT, Gootjes J, Zelle M, Madore DV, Verhoef J, Snippe H, Verheul AF.

Clin Diagn Lab Immunol. 1998 Sep;5(5):703-10.

19.

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.

Rennels MB, Edwards KM, Keyserling HL, Reisinger KS, Hogerman DA, Madore DV, Chang I, Paradiso PR, Malinoski FJ, Kimura A.

Pediatrics. 1998 Apr;101(4 Pt 1):604-11.

PMID:
9521941
20.

Impact of immunization on Haemophilus influenzae type b disease.

Madore DV.

Infect Agents Dis. 1996 Jan;5(1):8-20. Review.

PMID:
8789595
21.

Interlaboratory study evaluating quantitation of antibodies to Haemophilus influenzae type b polysaccharide by enzyme-linked immunosorbent assay.

Madore DV, Anderson P, Baxter BD, Carlone GM, Edwards KM, Hamilton RG, Holder P, Käyhty H, Phipps DC, Peeters CC, Schneerson R, Siber GR, Ward JI, Frasch CE.

Clin Diagn Lab Immunol. 1996 Jan;3(1):84-8.

22.

Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S.

Quataert SA, Kirch CS, Wiedl LJ, Phipps DC, Strohmeyer S, Cimino CO, Skuse J, Madore DV.

Clin Diagn Lab Immunol. 1995 Sep;2(5):590-7.

23.
24.

Safety and immunogenicity of a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine in young infants.

Paradiso PR, Hogerman DA, Madore DV, Keyserling H, King J, Reisinger KS, Blatter MM, Rothstein E, Bernstein HH, Hackell J.

Pediatrics. 1993 Dec;92(6):827-32.

PMID:
8233745
25.

Safety of combined oligosaccharide conjugate Haemophilus influenzae type b (HbOC) and whole cell diphtheria-tetanus toxoids-pertussis vaccine in infancy. The Kaiser Permanente Pediatric Vaccine Study Group.

Black SB, Shinefield HR, Ray P, Lewis EM, Fireman B, Hiatt R, Madore DV, Johnson CL, Hackell JG.

Pediatr Infect Dis J. 1993 Dec;12(12):981-5.

PMID:
8108224
26.
27.

Response of 7- to 15-month-old infants to sequential immunization with Haemophilus influenzae type b-CRM197 conjugate and polysaccharide vaccines.

Rothstein EP, Schiller RP, Girone JA, Hipp TJ, Souder RL, Bernstein HH, Madore DV, Johnson CL, Smith DH.

Am J Dis Child. 1991 Aug;145(8):898-900.

PMID:
1858727
28.

Comparison of antigenuria after immunization with three Haemophilus influenzae type b conjugate vaccines.

Rothstein EP, Madore DV, Girone JA, Schiller RP, Hipp TJ, Souder RL, Bernstein HH.

Pediatr Infect Dis J. 1991 Apr;10(4):311-4.

PMID:
2062627
29.

An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay.

Phipps DC, West J, Eby R, Koster M, Madore DV, Quataert SA.

J Immunol Methods. 1990 Dec 31;135(1-2):121-8.

PMID:
2273252
30.

Safety and immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in infants aged 15 to 23 months.

Madore DV, Johnson CL, Phipps DC, Myers MG, Eby R, Smith DH.

Pediatrics. 1990 Oct;86(4):527-34.

PMID:
2216616
31.
32.

Safety and immunologic response to Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in 1- to 6-month-old infants.

Madore DV, Johnson CL, Phipps DC, Popejoy LA, Eby R, Smith DH.

Pediatrics. 1990 Mar;85(3):331-7.

PMID:
2304786
33.

Haemophilus b oligosaccharide-CRM197 and other Haemophilus b conjugate vaccines: a status report.

Smith DH, Madore DV, Eby RJ, Anderson PW, Insel RA, Johnson CL.

Adv Exp Med Biol. 1989;251:65-82. Review. No abstract available.

PMID:
2692432
34.

Immune response of young children vaccinated with Haemophilus influenzae type b conjugate vaccines.

Madore DV, Phipps DC, Eby R, Johnson CL, Smith DH.

Contrib Microbiol Immunol. 1989;10:125-50. Review. No abstract available.

PMID:
2684505
35.

Standardization of antibody assays for measuring the response to pneumococcal infection and immunization.

Siber GR, Priehs C, Madore DV.

Pediatr Infect Dis J. 1989 Jan;8(1 Suppl):S84-91. Review. No abstract available.

PMID:
2648302

Supplemental Content

Loading ...
Support Center